Nobivac® Respira Bb
Nobivac Respira Bb offers protection against a significant cause for Canine Infectious Respiratory Disease (commonly referred to as canine cough or kennel cough) in the UK’s first injectable vaccine against Bordetella bronchiseptica. It is recommended for any dogs that regularly socialise or are kennelled with other dogs (e.g. boarding, dog training) where intranasal vaccination with Nobivac® KC is not the preferred or appropriate method. Dogs at risk of this whooping cough-like syndrome benefit from vaccination against this very common and widespread threat.
If you are looking at incorporating Nobivac Respira Bb into your protocol speak to your MSD Animal Health Account Manager or visit our Nobivac Protocol Builder.
Presentation
Aqueous, white to nearly white, mild creaming suspension for subcutaneous injection.
Active ingredients
Nobivac Respira Bb is an inactivated bacterial vaccine.
Per 1 ml dose vaccine:
88 - 399 U1 Bordetella bronchiseptica fimbriae2
1 Antigenic mass ELISA units
2 Purified from strain Bb7 92932
Also contains dl-α-tocopheryl acetate as an adjuvant and thiomersal as an excipient.
Target species
Dogs
Indications for use
For the active immunisation of dogs against Bordetella bronchiseptica to reduce clinical signs of upper respiratory tract disease and bacterial shedding post infection.
Packaging
Cardboard box with 1 multidose PET vial containing 10 doses (10 ml) of vaccine with a rubber stopper and aluminium cap.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: August 2023